Recent studies have shown that approximately 40% of patients undergoing diagnostic coronary angiography (CAG) for typical exertional chest pain have completely normal arteries or non-ob-Objectives: Intracoronary injection of acetylcholine (Ach) has been shown to induce significant coronary artery spasm (CAS) in patients with vasospastic angina. Clinical significance and angiographic characteristics of patients with ischemic electrocardiogram (ECG) changes during the Ach provocation test are not clarified yet. Methods: A total 4,418 consecutive patients underwent coronary angiography with Ach provocation tests from 2004 to 2012 were enrolled. Ischemic ECG changes were defined as transient ST-segment depression or elevation ( > 1 mm) and T inversion with/without chest pain. Finally, a total 2,293 patients (28.5% of total subjects) proven CAS were enrolled for this study. Results: A total 119 patients (5.2%) showed ECG changes during Ach provocation tests. The baseline clinical and procedural characteristics are well balanced between the two groups. Ischemic ECG change group showed more frequent chest pain, higher incidence of baseline spasm, severe vasospasm, multi-vessel involvement, and more diffuse spasm ( > 30 mm) than those without ischemic ECG changes. At 5 years, the incidences of death, major adverse cardiac events (MACE) and major adverse cardiac and cerebral events (MACCE) were higher in the ischemic ECG change group despite of optimal medical therapy. Conclusions: The patients with ischemic ECG changes during Ach provocation tests were associated with more frequent chest pain, baseline spasm, diffuse, severe and multi-vessel spasm than patients without ischemic ECG changes. At 5-years, the incidences of death, MACE and MACCE were higher in the ischemic ECG change group, suggesting more intensive medical therapy with close clinical follow up will be required.
structive coronary artery disease (CAD). [1] [2] [3] The normal CAG often leads the managing physician to make a diagnosis of non-cardiac chest pain.
However, in this situation, intracoronary injection of acetylcholine (Ach) during CAG is useful for induction of significant coronary artery spasm (CAS) in patients with vasospastic angina.
Recently, instead of intravenous administration of ergonovine, intracoronary Ach testing has been employed in the clinical setting. Previous study reported that the spasm provocation test with Ach has an acceptable level of safety, and the evaluation of spasm type may provide useful information for the risk stratification of CAS. 4 The coronary arteries of patients with vasospastic angina are hyper-reactive to diverse constrictor stimuli and occlusive constriction is readily induced by exposure to such a stimulus. The vascular effects of Ach on human coronary arteries are complex. 5 Our previous study reported that clinical and angiographic characteristics of Ach induced spasm were related to dose of intracoronary injection of Ach in patients with vasospastic angina. 6 However, clinical significance and angiographic characteristics of patients with vasospastic angina according to the ischemic electrocardiographic (ECG) changes during Ach provocation test are not clarified yet. In this study, we sought to clarify the impact of ischemic ECG changes during the Ach provocation test on clinical outcomes in patients with vasospastic angina during 5 years follow-up.
MATERIALS AND METHODS

Study population
We performed CAG in 8,052 consecutive patients (male 50.5%, mean age 54.6 ± 11.5 years) who had typical or atypical chest pain to diagnose or exclude significant CAD at cardiovascular cen- Association class III or IV), or serum creatinine ≥ 3 mg/dL, because these conditions can be major causes of adverse cardiovascular events and could serve as the bias of CAS. Finally, a total 2,293 patients (28.5% of total subjects underwent CAG) who showed angiographic proven CAS on Ach provocation test were enrolled for this study.
Those patients were divided into 2 groups according to ECG changes during Ach provocation tests and were analyzed. The study flow chart was shown in Figure 1 
Statistical analysis
All the statistical analyses were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA). For continuous variables, differences between two groups were evaluated by unpaired t-test or Mann-Whitney rank test. For discrete variables, differences were expressed as counts and percentages and analyzed with χ2 or Fisher's exact test between groups as appropriate. Multivariate logistic regression analysis, which included baseline confounding factors, was used for assessing the independent impact factors. Cumulative event proportions were calculated using Kaplan-Meier analyses. A two-tailed P-value of < 0.05 was considered to be statistically significant. Data were expressed as mean ± standard deviations.
RESULTS
The baseline clinical characteristics and laboratory findings of patients are shown in Table 1 .
The most value of age, hypertension, dyslipidemia, smoking history, chronic kidney disease, congenital heart failure were balanced between the two groups. Before the Ach provocation test, CCBs were more frequently prescribed for patients with ECG changes, but the frequency of the use of BBs, ACEIs, ARB, nitrates, and lipid-lowering drugs was similar between the two groups.
All patients had normal thyroid function in this study.
The baseline angiographic and ECG changes
during the Ach provocation test are shown in Table 2 . Before the Ach provocation test, at baseline CAG, the incidence of baseline spasm ( > 30%) was higher in patients with ischemic ECG changes than in those without ischemic ECG changes.
However, the frequency of myocardial bridge was similar between the two groups. Before the Ach provocation test, the reference diameters after NTG infusion were similar between the two groups. During the Ach provocation test, the incidence of significant CAS and Ach-induced ischemic chest pain was higher in patients with ischemic ECG changes.
After Ach infusion, the mean percentage narrowing on QCA was more severe in patients with ischemic ECG changes than in those without ECG changes. Univariate analysis showed that patients with ischemic ECG changes were associated with a higher incidence of baseline spasm, severe spasm, and multivessel involvement, and more diffuse spasms ( > 30 mm).
At the 5-year follow-up (mean follow-up duration 2272 ± 843 days), the incidence of total death (cardiac death and non-cardiac death rates), major adverse cardiac events (MACE), and major adverse cardiac and cerebral events (MACCE) were higher in patients with ischemic ECG changes than in those without ischemic ECG changes ( Kaplan-Meier curves showed that the cumulative incidence of MACE was higher in patients with ischemic ECG changes than in those without ischemic ECG changes at the 5-year follow-up (4.4% vs. 1.1%, P log-rank test = 0.004;)( Fig. 2 ).
DISCUSSION
The main findings of the present study are that the patients with ischemic ECG changes during Ach provocation tests were associated with more frequent ischemic chest pain, baseline spasm, diffuse, severe and multi-vessel spasm than patients 16 In our study, the ECG change group also showed more basal spasm (41.1%) than the no ECG change group, which suggest that basal coronary artery tone is increased in patients with vasospastic angina with higher disease activity at the spasm related artery and this may be related to the occurrence of CAS. 17, 18 In the context, we tested the hypothesis that 19 be the reason why the provocation rate for coronary spasm in patients with variant angina was lower in our study than that in the previous report. 20 prospectively. Therefore, further study is necessary to investigate the pathophysiology of spasms induced by Ach in patients with vasospastic angina. Sixth, because we enrolled the all patients who had chest pain (not concern about typical or atypical) without significant coronary artery stenosis, usual expected (+) rate of spasm might be higher in this study. This result could be happened. Therefore, we enrolled just > 70% diffuse coronary spasm which is not regarded as vasospastic angina currently.
In conclusion, the patients with ischemic ECG changes during the Ach provocation tests were associated with more frequent chest pain, baseline spasm, diffuse, severe and multi-vessel spasm than patients without ischemic ECG changes. At 5-year follow-up, the incidence of death, MACE and MACCE were higher in the ECG change group.
Therefore, in real world, the patients of vasospastic angina with ischemic ECG changee during Ach provocation test would require more aggressive and intensive medical therapy and careful clinical follow-up would be needed for these particular subsets of patients.
